Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 65 years old
- People who have been formally diagnosed with severe, persistent, non-allergic asthma by a lung specialist, following recognised international guidelines
- People whose test results show low levels of certain inflammation markers in the blood (a type of immune cell called eosinophils below a certain level, a negative allergy skin test, and/or low levels of a protein called IgE)
- People whose breathing tests show a meaningful improvement after using a reliever inhaler (confirm with trial site for exact test details)
- People who were diagnosed with asthma at least 6 months ago and have been receiving ongoing care and treatment
- People who have completed a pulmonary rehabilitation program (a structured exercise and education program for lung conditions)
- People who have completed 8 weeks of a breathing muscle training program called inspiratory muscle training (IMT)
- People who have read, understood, and signed a consent form agreeing to take part
Who may not be able to join:
- People who have had a respiratory infection (such as a chest or airway infection) within the past month
- People with a significant smoking history (more than 10 pack-years) or who have smoked within the last 6 months
- People who have taken oral steroid tablets (such as prednisone or cortisone) within the past 4 weeks
- People with a Body Mass Index (BMI) over 35 (a measure of body weight relative to height)
- People diagnosed with certain specific conditions affecting the lungs and blood vessels, including Eosinophilic Granulomatosis with Polyangiitis (EGPA) or Allergic Bronchopulmonary Aspergillosis (ABPA) (confirm with trial site)
- People with a condition called vasculitis (inflammation of the blood vessels)
- People with a personal history of cancer
- People who are pregnant
- People who have previously had lung surgery or who currently use long-term oxygen therapy at home
- People with certain spine or joint conditions (such as severe kyphoscoliosis or ankylosing spondylitis) or nerve and muscle conditions (such as myasthenia gravis, muscular dystrophies, or myopathies) that could affect breathing tests or participation in rehabilitation
- People with significant cognitive difficulties, intellectual disability, dementia, or other conditions that may make it hard to follow the study plan
- People who are unwilling to continue participating throughout the study
- People with significant communication difficulties or intellectual challenges that may affect participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +90 216 777 96 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient-reported experiences of inspiratory muscle training (IMT) assessed by semi-structured in-depth interviews (study-specific interview guide); Experience of exercising using telerehabilitation assessed by semi-structured in-depth interviews (study-specific interview guide); Changes in physical activity in daily life assessed by semi-structured in-depth interviews (study-specific interview guide); Self-management skills assessed by semi-structured in-depth interviews (study-specific interview guide); Coping strategies assessed by semi-structured in-depth interviews (study-specific intervie...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.